can small cell lung cancer spread to the bones
Báo cáo khoa học: "Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: report from the Quality Assurance Working Party of the randomised phase III ROSEL study" pps
Ngày tải lên :
09/08/2014, 09:22
... body radiotherapy for stage I
non -small cell lung cancer. Radiother Oncol 2007, 85:429-434.
39. Sinha B, McGarry RC: Stereotactic body radiotherapy for bilat-
eral primary lung cancers: the Indiana ... base) for purposes of
contouring will begin at the level of the inferior aspect of
the aortic arch (aorto-pulmonary window) and extend
inferiorly to the apex of the heart.
The defined ipsilateral ... corrections due to tumour shifts lead
to a change in the dose given to the OAR. To avoid exces-
sive doses to OAR, it is recommended to evaluate the
impact of such shifts on the OAR dose during treatment
planning....
- 14
- 308
- 0
Báo cáo hóa học: "Involvement of aryl hydrocarbon receptor signaling in the development of small cell lung cancer induced by HPV E6/E7 oncoproteins" ppt
Ngày tải lên :
18/06/2014, 16:20
... Martinelli
1,4*
Abstract
Background: Lung cancers consist of four major types that and for clinical-pathological reasons are often divided
into two broad categories: small cell lung cancer (SCLC) and non -small cell lung cancer ... in the development of oral can-
cer [28], esophageal cancer [29] and colorectal cancer
[30]. Furthermore the association between the presence
of HPV 16 and the development of head and neck cancer
has ... act as a risk marker of lung cancer in Taiwan. Cancer 2003,
97:1558-1563.
11. Klein F, Amin Kotb WF, Petersen I: Incidence of human papilloma virus in
lung cancer. Lung Cancer 2009, 65:13-18.
12....
- 11
- 471
- 0
Báo cáo khoa học: "The effect of bioequivalent radiation dose on survival of patients with limited-stage small-cell lung cancer" pdf
Ngày tải lên :
09/08/2014, 09:20
... morphological characteristics of
permanent human small cell lung cancer cell lines. J Cancer Res Clin
Oncol 1987, 113:31-40.
16. NCCN guidelines for small- cell lung cancer. [http://www.nccn.org/
professionals/physician_gls/f_guidelines.asp].
17. ... radiotherapy in limited-stage small
cell lung cancer: facts, questions, prospects. Radiother Oncol 2000, 55:1-9.
2. Murray N, Turrisi AT: A review of first-line treatment for small- cell lung
cancer. ... interruptions to palliate the
toxicity from concurrent chemoradiation for limited small cell lung
cancer decreases survival and disease control. Lung Cancer 2001,
33:249-258.
26. Cisplatin, etoposide,...
- 9
- 465
- 0
Báo cáo khoa học: "Radiotherapy quality assurance review in a multi-center randomized trial of limited-disease small cell lung cancer: the Japan Clinical Oncology Group (JCOG) trial 0202" pptx
Ngày tải lên :
09/08/2014, 09:22
... National Cancer Center 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan and
3
JCOG lung cancer study group, Thoracic
Oncology Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo ... consolidation chemotherapy after concurrent
chemoradiotherapy for limited-disease small cell lung
cancer (Figure 1).
The primary endpoint of JCOG 0202 was overall survival
and the secondary endpoints ... better comply with the
treatment protocol by the RT principal investigator, which
enabled participants to follow the protocol guidelines in
their later cases.
In the current study, more suboptimal...
- 5
- 293
- 0
báo cáo hóa học:" Randomized phase II study with two gemcitabine- and docetaxel-based combinations as first-line chemotherapy for metastatic non-small cell lung cancer" docx
Ngày tải lên :
18/06/2014, 15:20
... Pisani P: Estimating the world cancer
burden: Globocan 2000. Int J Cancer 2001, 94:153-156.
2. Non -small Cell Lung Cancer Collaborative Group: Chemotherapy
in non small cell lung cancer: a meta-analysis ... G,
Gozzelino F, Tonato M: Gemcitabine and cisplatin versus mito-
mycin, ifosfamide, and cisplatin in advanced non -small- cell
lung cancer: a randomized phase III study of the Italian Lung
Cancer Project. ... cisplatin-teniposide in patients with
advanced non -small- cell lung cancer. The European Organi-
zation for Research and Treatment of Cancer Lung Cancer
Cooperative Group. J Clin Oncol 1998, 16:2133-2141.
7....
- 8
- 538
- 0
Báo cáo hóa học: " Detection of EGFR mutations with mutation-specific antibodies in stage IV non-small-cell lung cancer" pdf
Ngày tải lên :
18/06/2014, 16:20
... Non -small- cell lung cancer harbouring mutations in the EGFR
kinase domain. Clin Transl Oncol 2010, 12:75-80.
9. Gazdar AF: Activating and resistance mutations of EGFR in non -small- cell
lung cancer: ... factor
receptor mutations in lung cancer. Nat Rev Cancer 2007, 7:169-181.
3. Kosaka T, Yatabe Y, Endoh H, Kuwano H, Takahashi T, Mitsudomi T:
Mutations of the epidermal growth factor receptor ... for the detection of
EGFR mutations in non -small- cell lung cancer. Clin Cancer Res 2009,
15:3023-3028.
13. Motoi N, Szoke J, Riely GJ, Seshan VE, Kris MG, Rusch VW, Gerald WL,
Travis WD: Lung...
- 8
- 798
- 0
Báo cáo hóa học: "Prognostic Impact of MiR-155 in Non-Small Cell Lung Cancer Evaluated by in Situ Hybridization" pot
Ngày tải lên :
18/06/2014, 16:20
... in the cytoplasm of most neo-
plastic tumor cells and to a lesser extent expressed in
the cytoplasm of normal epithelial cells in lung tissue.
Based on m orphological cr iteria, infla mmatory cells
(macrophages, ... marker expression in tumor cells versus stromal cells in non
small cell lung cancer. Clin Cancer Res 2007, 13:6649-57.
24. World Health Organization: Histological Typing of Lung and Pleural
Tumours. ... according to NSCLC histology. Lung Cancer 2010.
31. Donnem T, Al-Saad S, Al-Shibli K, Andersen S, Busund LT, Bremnes RM:
Prognostic impact of platelet-derived growth factors in non -small cell
lung cancer...
- 9
- 662
- 0
báo cáo hóa học: " Health state utilities for non small cell lung cancer" pot
Ngày tải lên :
18/06/2014, 19:20
... breast cancer. Br J Cancer 2006,
95(6):683-90.
17. Cancer Research UK [http://www.cancerresearchuk.org
]
18. Cancer Help [http://www.cancerhelp.org.uk
]
19. Association for International Cancer ... is the most com-
mon and the most life-threatening form of cancer in Scot-
land [2]. Lung cancer is also a major cause of death
throughout the rest of the world [3,4].
Non -small cell lung cancer ... Staging of small cell
and non -small cell lung cancer. University of Iowa Virtual Hos-
pital; 1999.
6. Hopwood P, Stephens RJ: Symptoms at presentation for treat-
ment in patients with lung cancer: ...
- 15
- 397
- 0
Báo cáo toán học: "Molecular Predictors of EGFR-TKI Sensitivity in Advanced Non–small Cell Lung Cancer" ppsx
Ngày tải lên :
08/08/2014, 17:20
...
cancers and the leading cause of cancer death world-
wide (1). Lung cancer is generally classified into two
histological types, small cell lung cancer (SCLC) and
non small cell lung cancer (NSCLC).
... sensitivity to gefitinib in non -small cell lung cancer
cell lines. Mol Cancer Res. 2006; 4(8): 521-8.
102. Taguchi F, Solomon B, Gregorc V, et al. Mass spectrometry to
classify non -small- cell lung cancer ... EGFR-TKIs therapy.
Key words: non -small cell lung cancer, EGFR, somatic mutation, tyrosine kinase inhibitor, gene amplification
Introduction
Lung cancer is one of the most common human
cancers...
- 9
- 203
- 0
Báo cáo khoa học: "Pathological complete response induced by first-line chemotherapy with single agent docetaxel in a patient with advanced non small cell lung cancer" pptx
Ngày tải lên :
09/08/2014, 03:21
... chemotherapy resulted in further tumor
shrinkage, with no additional toxicity, and gave the
patient the possibility to undergo a lobectomy rather
than a pneumectomy, with the obvious advantages of ... treatment-related deaths ( 5 in the
DC arm vs 1 in the D arm)[6].
Similarly, the toxicity profile of the monotherapy arm
in the Lilenbaum [7] study was more favorable com-
pared with that of the combination ... Defining the optimal treatment for patients with inoperable non small cell lung cancer (NSCLC),
presenting with metastatic mediastinal lymph nodes, is challenging. Nevertheless, preoperative chemotherapy...
- 4
- 303
- 0
Báo cáo khoa học: "Analysis of clinical and dosimetric factors associated with severe acute radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent chemotherapy and intensity-modulated radiotherapy" pot
Ngày tải lên :
09/08/2014, 08:23
... models
The total normal lung volume was defined as the total
lung volume minus the primary GTV and volume of the
trachea and main bronchi. From each lung DVH, the fol-
lowing dosimetric factors ... V10 are the useful indicators for predicting SARP in NSCLC patients treated with
concurrent chemotherapy and IMRT.
Background
Lung cancer is the leading cause of cancer- related death
in the urban ... Xu
Abstract
Background: To evaluate the association between the clinical, dosimetric factors and severe acute radiation
pneumonitis (SARP) in patients with locally advanced non -small cell lung cancer (LANSCLC)...
- 8
- 371
- 0
Báo cáo khoa học: "Clinical outcomes of stereotactic body radiotherapy for stage I non-small cell lung cancer using different doses depending on tumor size" ppsx
Ngày tải lên :
09/08/2014, 09:20
... radiotherapy
in treatment of stage I non -small cell lung cancer. Lung Cancer 2003,
41:1-11.
17. Shibamoto Y, Yukawa Y, Tsutsui K, Takahashi M, Abe M: Variation in the
hypoxic fraction among mouse tumors ... for stage I primary lung cancer and oligometa-
static lung cancer. Promising clinical results have been
reported despite the use of various treatment protocols
[2-9]. According to a recently published ... with
our prospective hypothesis-driven protocol.
Methods
Eligibility Criteria
The eligibility criteria were as follows: histologi cally-
confirmed non -small cell lung cancer (NSCLC)
* Correspondence:...
- 7
- 297
- 0
Báo cáo khoa học: " Comparison of outcomes in patients with stage III versus limited stage IV non-small cell lung cancer" docx
Ngày tải lên :
09/08/2014, 09:20
... Stereotactic Body Rad iotherapy, Oligometastases, Non -Small Cell Lung Cancer
Background
Non -small cell lung cancer (NSCLC) is the leading
cause of cancer mortality in the United States [1].
Patients ... progression and was postulated
to be a poor prognostic factor in lung cancer. Similarly,
Bradley et al. demonstrated the prognostic value of
GTV determined on planning CT scans to be associated
with OS ... with regard to the extent of disease spread,
cancer burde n (i.e. bulk), performance status, and other
prognostic factors. As previously postulated by Drs.
Hellman and Weichselbaum, the metastatic...
- 7
- 368
- 0